Biogen collaborates with San Raffaele Telethon Institute for Gene Therapy in hemophilia A and B
Biogen Inc. teamed up with San Raffaele Telethon Institute for Gene Therapy to create gene therapeutics for hemophilia...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Tech Transfer Deals column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced January through February 2015.
Biogen collaborates with San Raffaele Telethon Institute for Gene Therapy in hemophilia A and B
Biogen Inc. teamed up with San Raffaele Telethon Institute for Gene Therapy to create gene therapeutics for hemophilia...
The firm is concentrating on its Keytruda combo for head and neck cancer after being abandoned by Roche and boardroom battles.
The deal, which could be worth as much as $360m, marks the Danbury, CT-based firm's strategic expansion into cardiorenal medicine.
Mid-sized, diversified Japanese group teams up with Singaporean wholesaler Formiica and Japanese trading/contract services firm CBC for Singapore JV focused on in-licensing in Asia/Oceania.